Kate Therapeutics
New Hope for Patients with Muscle and Heart Disease
48 employees · est. 2020 · San Diego, United States
M6P Therapeutics
Next generation enzyme replacement and gene therapies for rare diseases.
20 employees · est. 2017 · United States
M6P Therapeutics is the older company (2020 vs 2017).
Side-by-Side Comparison
| Metric | Kate Therapeutics | M6P Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2017 older |
| Headquarters | ||
| Headquarters | San Diego, United States | United States |
| Employees | ||
| Employees | 48 | 20 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Acquired | Not tracked yet |
| Total Funding | ||
| Total Funding | $1.17B | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | Not tracked yet |
| Services | ||
| Services | Innovative Medicine Development, Research & Development, Clinical Trials, Therapeutic Solutions, Gene Therapies | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients, Healthcare Professionals, Caregivers, Researchers, Investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Gene Therapies, Adeno-associated Virus, AAV-based Technology, Muscle Diseases, Heart Diseases, Tissue-specific Delivery, Gene Regulation, Genetically Defined Diseases, Novel Technology Platforms, Efficacy Improvement, Safety Enhancement, Broader Drug Targets, Patient-focused Approach | Enzyme Replacement Therapy, Gene Therapy, Lysosomal Storage Disorders, Rare Diseases, Clinical Research, Novel Therapies, M6P Phosphorylation, Enzyme Delivery, Research Solutions, Biotechnology Advances, Lysosomal Storage Diseases |
| Website | ||
| Website | katetherapeutics.com | m6ptherapeutics.com |
About Kate Therapeutics
Kate Therapeutics (KateTx) is a pioneering player in the biotechnology sector, focusing on groundbreaking solutions for genetically defined muscle and heart diseases. Founded in 2020, this United States-based company is spearheading the development of adeno-associated virus (AAV)-based gene therapie...
About M6P Therapeutics
M6P Therapeutics is a biotech startup founded in 2017, with a focus on developing next-generation enzyme replacement and gene therapies for lysosomal storage disorders. Their slogan "Next generation enzyme replacement and gene therapies for rare diseases" encapsulates their mission. The company has...
We will tell you when either one moves
BounceWatch watches Kate Therapeutics and M6P Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kate Therapeutics and M6P Therapeutics — by email.
Frequently Asked Questions
Compare Kate Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Kate Therapeutics on 28 Jan 2026, and M6P Therapeutics on 23 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.